Upcoming live webinar with Q&A

Reshaping prenatal care: In-utero therapies and the impact of early genetic insights

Date: Wednesday, June 10, 2026

Time: 11:00 AM PT | 2:00 PM ET

Webinar duration: 45 minutes

Registrants will receive a recording of the webinar approximately one week after the event.

Advances in in-utero therapies are reshaping what’s possible in prenatal care. As investigational therapies emerge for inherited single-gene conditions, earlier identification is becoming more critical. Identifying affected pregnancies earlier can guide care, inform timely referrals, and expand patient opportunities to access specialized therapies and clinical trials.

Join Dr. Hiba J. Mustafa, MFM and fetal treatment specialist at Riley Children's and Indiana University Health, as she shares her firsthand experience with in-utero therapies and how this evolving field is transforming prenatal care.

Genetic counselor and Natera’s Medical Science Liaison, Erin Armenti, will highlight how single-gene NIPT can enable earlier diagnosis and treatment.

Learn more about:

The current landscape of in-utero therapies for inherited single-gene conditions, such as cystic fibrosis
How prenatal genetic testing like Horizon™ carrier screening and Fetal Focus™ single-gene NIPT can support earlier, more actionable insights
Screening and care coordination considerations for OB/GYNs as in-utero therapies continue to evolve

The webinar will conclude with a live Q&A section with the speakers.

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Our speakers

Hiba J. Mustafa, MD, FACOG

MFM Specialist and Director of Fetal Center and Fetal Surgery

Riley Children’s Health, Indiana University School of Medicine

Erin Armenti, MS, LCGC

Medical Science Liaison, Manager

Natera, Women’s Health

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the tests. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy